
ERNA Valuation
Ernexa Therapeutics Inc
- Overview
- Forecast
- Valuation
- Earnings
ERNA Relative Valuation
ERNA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ERNA is overvalued; if below, it's undervalued.
Historical Valuation
Ernexa Therapeutics Inc (ERNA) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -3.51. The fair price of Ernexa Therapeutics Inc (ERNA) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price:1.83
Fair
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
-1.23
P/B
Median3y
1.17
Median5y
-6.44
-88.65
FCF Yield
Median3y
-164.57
Median5y
-119.22
Competitors Valuation Multiple
The average P/S ratio for ERNA's competitors is 0.06, providing a benchmark for relative valuation. Ernexa Therapeutics Inc Corp (ERNA) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of -100.00%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
People Also Watch

PSHG
Performance Shipping Inc
1.820
USD
-4.11%

DRCT
Direct Digital Holdings Inc
0.556
USD
+2.77%

INHD
Inno Holdings Inc
1.410
USD
-0.70%

SNTI
Senti Biosciences Inc
1.930
USD
-3.02%

NWGL
Nature Wood Group Ltd
1.050
USD
+1.94%

CDIO
Cardio Diagnostics Holdings Inc
4.387
USD
-4.21%

INAB
IN8bio Inc
2.440
USD
+1.24%

SHFS
SHF Holdings Inc
3.270
USD
-1.21%

SFHG
Samfine Creation Holdings Group Ltd
0.807
USD
+3.86%

ELBM
Electra Battery Materials Corp
1.290
USD
-0.39%
FAQ

Is Ernexa Therapeutics Inc (ERNA) currently overvalued or undervalued?
Ernexa Therapeutics Inc (ERNA) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -3.51. The fair price of Ernexa Therapeutics Inc (ERNA) is between to according to relative valuation methord.

What is Ernexa Therapeutics Inc (ERNA) fair value?

How does ERNA's valuation metrics compare to the industry average?

What is the current P/B ratio for Ernexa Therapeutics Inc (ERNA) as of Jul 26 2025?

What is the current FCF Yield for Ernexa Therapeutics Inc (ERNA) as of Jul 26 2025?

What is the current Forward P/E ratio for Ernexa Therapeutics Inc (ERNA) as of Jul 26 2025?
